Literature DB >> 8000504

Intestinal and extraintestinal complications of Crohn's disease: predictors and cumulative probability of complications.

K Maeda1, M Okada, T Yao, T Sakurai, M Iida, T Fuchigami, K Yoshinaga, K Imamura, Y Okada, K Sakamoto.   

Abstract

Of 238 patients with Crohn's disease seen at our clinics from April 1973 to August 1988, 203 patients were selected for this study, since they fulfilled the following criteria: they had been followed up for more than 6 months as outpatients or had been treated as inpatients for more than 1 month. They were studied to elucidate: (a) the different types and incidence of various complications, (b) the factors related to complications present at the time of diagnosis, (c) predictors of new complications arising after diagnosis, and (d) the cumulative incidence of complications occurring during the course of the disease from the times of onset and diagnosis. Of the intestinal complications, perianal fistula was most common (33%), followed by strictures with dilatations of the proximal bowel (21%), and internal fistula (14%). Of the extraintestinal complications, menstrual disturbance was the most common (18% of the female patients), followed by arthritis (10%), and aphthous stomatitis (10%). As for the factors influencing complications present at the time of diagnosis, the pattern of bowel involvement was significantly correlated with the presence of intestinal stricture, while the erythrocyte sedimentation rate was significantly correlated with the presence of perianal fistula. A significant predictor of new complications arising after diagnosis was the general well-being of patients at the time of diagnosis. Patients who, at diagnosis, already have complications such as stricture, abdominal abscess, internal or external fistula, massive hemorrhage, and free perforation or anal lesions are more likely to develop new complications in addition to those present at diagnosis, compared with patients without any complications at diagnosis (P = 0.055).

Entities:  

Mesh:

Year:  1994        PMID: 8000504     DOI: 10.1007/BF02365438

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  14 in total

1.  Clinical patterns in Crohn's disease: a statistical study of 615 cases.

Authors:  R G Farmer; W A Hawk; R B Turnbull
Journal:  Gastroenterology       Date:  1975-04       Impact factor: 22.682

2.  Erythrocyte sedimentation as a measure of Crohn's disease activity: opposite trends in ileitis versus colitis.

Authors:  D B Sachar; N E Luppescu; C Bodian; R D Shlien; T L Fabry; V V Gumaste
Journal:  J Clin Gastroenterol       Date:  1990-12       Impact factor: 3.062

3.  Clinical and pathological differentiation of Crohn's disease and proctocolitis.

Authors:  J E Lennard-Jones; H E Lockhart-Mummery; B C Morson
Journal:  Gastroenterology       Date:  1968-06       Impact factor: 22.682

4.  Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.

Authors:  W R Best; J M Becktel; J W Singleton; F Kern
Journal:  Gastroenterology       Date:  1976-03       Impact factor: 22.682

5.  [Clinical features of Crohn's disease: relationship of disease type and severity to clinical findings at the time of diagnosis in 166 cases].

Authors:  M Tominaga
Journal:  Fukuoka Igaku Zasshi       Date:  1992-01

6.  Crohn's disease. Treatment and outcome.

Authors:  E Lind; O Fausa; E Gjone; S B Mogensen
Journal:  Scand J Gastroenterol       Date:  1985-10       Impact factor: 2.423

7.  [Long-term prognosis of Crohn's disease].

Authors:  T Nakahara; T Yao; T Sakurai; M Okada; M Iida; T Fuchigami; K Tanaka; Y Okada; K Sakamoto; M Sata
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  1991-06

8.  Analysis of clinical course of postoperative recurrence in Crohn's disease of distal ileum.

Authors:  F Pallone; M Boirivant; M A Stazi; R Cosintino; C Prantera; A Torsoli
Journal:  Dig Dis Sci       Date:  1992-02       Impact factor: 3.199

9.  Long-term follow-up of patients with Crohn's disease. Relationship between the clinical pattern and prognosis.

Authors:  R G Farmer; G Whelan; V W Fazio
Journal:  Gastroenterology       Date:  1985-06       Impact factor: 22.682

10.  Anatomical involvement and clinical features in 91 Japanese patients with Crohn's disease.

Authors:  M Okada; T Yao; T Fuchigami; M Iida; H Date
Journal:  J Clin Gastroenterol       Date:  1987-04       Impact factor: 3.062

View more
  8 in total

1.  Inflammatory bowel disease associated arthropathy.

Authors:  Sheila L Arvikar; Mark C Fisher
Journal:  Curr Rev Musculoskelet Med       Date:  2011-09

2.  Treatment of pediatric refractory Crohn's disease with thalidomide.

Authors:  Cui-Fang Zheng; Jia-Hua Xu; Ying Huang; Ying-Kit Leung
Journal:  World J Gastroenterol       Date:  2011-03-14       Impact factor: 5.742

Review 3.  Current clinical issue of skin lesions in patients with inflammatory bowel disease.

Authors:  Tomoya Iida; Tokimasa Hida; Minoru Matsuura; Hisashi Uhara; Hiroshi Nakase
Journal:  Clin J Gastroenterol       Date:  2019-03-05

4.  A cross-sectional study of 130 Brazilian patients with Crohn's disease and ulcerative colitis: analysis of articular and ophthalmologic manifestations.

Authors:  Cristina Costa Duarte Lanna; Maria de Lourdes Abreu Ferrari; Sidney Lemos Rocha; Evaldo Nascimento; Marco Antônio Parreiras de Carvalho; Aloísio Sales da Cunha
Journal:  Clin Rheumatol       Date:  2007-12-21       Impact factor: 2.980

Review 5.  Clinical features and epidemiology of spondyloarthritides associated with inflammatory bowel disease.

Authors:  Carlo Salvarani; Walter Fries
Journal:  World J Gastroenterol       Date:  2009-05-28       Impact factor: 5.742

Review 6.  Rheumatological manifestations in inflammatory bowel disease.

Authors:  Paraskevi V Voulgari
Journal:  Ann Gastroenterol       Date:  2011

7.  Dendritic cells in IBD pathogenesis: an area of therapeutic opportunity?

Authors:  Jennifer Bates; Lauri Diehl
Journal:  J Pathol       Date:  2014-01       Impact factor: 7.996

8.  Predicting Outcomes to Optimize Disease Management in Inflammatory Bowel Diseases.

Authors:  Joana Torres; Flavio Caprioli; Konstantinos H Katsanos; Triana Lobatón; Dejan Micic; Marco Zerôncio; Gert Van Assche; James C Lee; James O Lindsay; David T Rubin; Remo Panaccione; Jean-Frédéric Colombel
Journal:  J Crohns Colitis       Date:  2016-06-09       Impact factor: 9.071

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.